1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) is sponsored by National Cancer Institute (NCI). This program, involving the University of Colorado Cancer Center, focuses on evaluating the benefits and harms of new cancer screening technologies and their impacts on a representative sample of the U. S.
population.
Get alerted about grants like this
Save a search for “National Cancer Institute (NCI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funded Early Detection and Screening Grants | Division of Cancer Prevention Funded Early Detection and Screening Grants Active Grants Completed Grants Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma University Of Colorado Denver Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) Elyse LeeVan, M. D. , M.
P. H. Fred Hutchinson Cancer Center NCI Cancer Screening Research Network: Coordinating and Communication Center Elyse LeeVan, M.
D. , M. P.
H. Fred Hutchinson Cancer Center Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) Elyse LeeVan, M. D.
, M. P. H.
University Of Oklahoma Hlth Sciences Ctr Oklahoma TRUST Access Hub Elyse LeeVan, M. D. , M.
P. H. Virginia Commonwealth University Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) Elyse LeeVan, M.
D. , M. P.
H. Kaiser Foundation Research Institute Multi-Cancer Early Detection and Screening (MED SCREEN) Study Elyse LeeVan, M. D.
, M. P. H.
Neslund-Dudas, Christine Marie Henry Ford Health + Michigan State University Health Sciences HFH-MSU CSRN ACCrual Enrollment and Screening Site Elyse LeeVan, M. D. , M.
P. H. Univ Of North Carolina Chapel Hill Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) Elyse LeeVan, M.
D. , M. P.
H. Siteman Cancer Center Catchment CSRN ACCESS Hub Elyse LeeVan, M. D.
, M. P. H.
Weizmann Institute Of Science Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort Fred Hutchinson Cancer Center Statistical Methods for Precision Prevention Massachusetts General Hospital Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls University Of Tx Md Anderson Can Ctr Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data
According to the current listing, eligibility includes: University of Colorado Denver and partner institutions; this is a funded cooperative agreement, not an open solicitation. Confirm the full requirements in the official notice before applying.
Applications for I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) are due December 31, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Colorado. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is a grant from the National Institutes of Health (NIH) / National Cancer Institute (NCI) that funds early-stage postdoctoral researchers in cancer-related fields to transition to independent research careers. The award provides a mentored phase (K99) followed by an independent phase (R00), supporting investigators who do not require an extended period of supervised training beyond their doctoral degrees. Eligible applicants must hold a research or clinical doctoral degree and be postdoctoral fellows who have not yet established independent research careers. The March 11, 2026 due date applies; award amounts vary by project.